Literature DB >> 10564793

Cloning and sequences of inducible and constitutive macrolide resistance genes in Staphylococcus aureus that correspond to an ABC transporter.

M Matsuoka1, L Jánosi, K Endou, Y Nakajima.   

Abstract

A restriction map was made and the DNA sequence was determined for a plasmid, pMC38, derived from the inducible macrolide resistance plasmid pEP2104, that showed constitutive resistance to PMS antibiotics (partial macrolide and streptogramin B antibiotics). A 5. 04 kb SalI-PstI fragment (fragment C) of pMC38, which encoded PMS resistance, was cloned into a shuttle vector, pRIT5, to yield pMR504. The transformant Staphylococcus aureus 4220 (pMR504) exhibited constitutive PMS resistance. Fragment C was subcloned to pUC19 in order to determine the DNA sequence. This sequence was consequently found to contain three open reading frames (ORF1-3), of which ORF3 corresponded to the 63 kDa membrane protein (MsrSA) that expressed PMS resistance. According to DNA sequence comparison of the control region of ORF3 in pMC38 and pEP2104, 44 nucleotides including RBS1 and the leader peptide (MTASMRLK) were deleted on plasmid pMC38. This suggests that the leader peptide is essential for the inducible expression of PMS resistance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10564793     DOI: 10.1111/j.1574-6968.1999.tb08830.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  16 in total

1.  Induction of telithromycin resistance by erythromycin in isolates of macrolide-resistant Staphylococcus spp.

Authors:  Kepler A Davis; Sharon A Crawford; Kristin R Fiebelkorn; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

Review 2.  The macrolide antibiotic renaissance.

Authors:  George P Dinos
Journal:  Br J Pharmacol       Date:  2017-08-10       Impact factor: 8.739

3.  Molecular analysis of resistance to streptogramin A compounds conferred by the Vga proteins of staphylococci.

Authors:  Olivier Chesneau; Heidi Ligeret; Negin Hosan-Aghaie; Anne Morvan; Elie Dassa
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  A new evolutionary variant of the streptogramin A resistance protein, Vga(A)LC, from Staphylococcus haemolyticus with shifted substrate specificity towards lincosamides.

Authors:  G Novotna; J Janata
Journal:  Antimicrob Agents Chemother       Date:  2006-10-02       Impact factor: 5.191

5.  Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible.

Authors:  Karita D Ambrose; Rebecca Nisbet; David S Stephens
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

6.  Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae.

Authors:  M Santagati; F Iannelli; M R Oggioni; S Stefani; G Pozzi
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

7.  An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin.

Authors:  Kavindra V Singh; George M Weinstock; Barbara E Murray
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

8.  Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility.

Authors:  K V Singh; K Malathum; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

Review 9.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

10.  Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates.

Authors:  Melissa M Daly; Stella Doktor; Robert Flamm; Dee Shortridge
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.